Maximus, Inc. (NYSE:MMS) Insider Teresa Weipert Sells 1,444 Shares of Stock

Maximus, Inc. (NYSE:MMSGet Free Report) insider Teresa Weipert sold 1,444 shares of the stock in a transaction that occurred on Friday, September 29th. The shares were sold at an average price of $74.68, for a total transaction of $107,837.92. Following the completion of the transaction, the insider now owns 5,493 shares in the company, valued at $410,217.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Maximus Trading Down 0.5 %

NYSE MMS opened at $74.33 on Tuesday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.46 and a current ratio of 1.46. The firm has a market cap of $4.52 billion, a PE ratio of 26.55 and a beta of 0.71. Maximus, Inc. has a one year low of $54.46 and a one year high of $89.69. The firm’s fifty day moving average is $79.82 and its two-hundred day moving average is $81.35.

Maximus (NYSE:MMSGet Free Report) last announced its earnings results on Wednesday, August 2nd. The health services provider reported $0.78 earnings per share for the quarter, missing the consensus estimate of $1.14 by ($0.36). Maximus had a net margin of 3.56% and a return on equity of 15.11%. The company had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.20 billion. During the same quarter last year, the business posted $0.78 earnings per share. The company’s revenue for the quarter was up 5.6% compared to the same quarter last year. Analysts expect that Maximus, Inc. will post 3.88 earnings per share for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, August 31st. Stockholders of record on Tuesday, August 15th were paid a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.51%. The ex-dividend date was Monday, August 14th. Maximus’s dividend payout ratio (DPR) is presently 40.00%.

Institutional Trading of Maximus

Institutional investors have recently modified their holdings of the business. Farther Finance Advisors LLC boosted its position in shares of Maximus by 71.7% during the 2nd quarter. Farther Finance Advisors LLC now owns 352 shares of the health services provider’s stock worth $30,000 after purchasing an additional 147 shares in the last quarter. Quadrant Capital Group LLC lifted its stake in shares of Maximus by 119.8% in the fourth quarter. Quadrant Capital Group LLC now owns 389 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 212 shares during the period. Macquarie Group Ltd. purchased a new stake in Maximus during the first quarter worth about $35,000. Harbor Capital Advisors Inc. acquired a new position in Maximus during the second quarter worth about $46,000. Finally, Fifth Third Bancorp increased its holdings in Maximus by 26.0% in the first quarter. Fifth Third Bancorp now owns 728 shares of the health services provider’s stock valued at $57,000 after buying an additional 150 shares in the last quarter. 99.30% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

MMS has been the subject of several research analyst reports. Stifel Nicolaus initiated coverage on shares of Maximus in a research note on Friday, August 18th. They issued a “buy” rating and a $102.00 price objective for the company. TheStreet cut Maximus from a “b” rating to a “c+” rating in a research note on Tuesday, August 15th. Finally, StockNews.com initiated coverage on Maximus in a research note on Thursday, August 17th. They issued a “hold” rating for the company.

Get Our Latest Stock Report on Maximus

Maximus Company Profile

(Get Free Report)

Maximus, Inc provides business process services (BPS) to government health and human services programs. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

See Also

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.